FDA moves toward easing restrictions on certain peptides BioPharma Dive Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The peptide problem: Hype is outrunning the evidence